Default object view. Click to create a custom template, Node ID: 111777, Object ID: 66801

A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-s...

A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)

No relation

Yes

No relation

No

21/05/2015 10:50 am

No